TY  - JOUR
AU  - Domínguez, Juan Manuel
AU  - Pérez-Chacón, Gema
AU  - Guillén, María José
AU  - Muñoz-Alonso, María José
AU  - Somovilla-Crespo, Beatriz
AU  - Cibrian, Danay
AU  - Acosta-Iborra, Bárbara
AU  - Adrados, Magdalena
AU  - Muñoz-Calleja, Cecilia
AU  - Cuevas, Carmen
AU  - Sanchez-Madrid, Francisco
AU  - Avilés, Pablo
AU  - Zapata, Juan M
PY  - 2020
DO  - 10.1186/s13045-020-00865-7
SN  - 1756-8722
UR  - http://hdl.handle.net/20.500.12105/9633
AB  - BACKGROUND: In the search for novel antibody-drug conjugates (ADCs) with therapeutic potential, it is imperative to identify novel targets to direct the antibody moiety. CD13 seems an attractive ADC target as it shows a differential pattern of...
LA  - eng
PB  - BioMed Central (BMC)
KW  - ADC
KW  - Aminopeptidase-N
KW  - Antibody-drug conjugate
KW  - CD13
KW  - Endocytosis
KW  - Fibrosarcoma
KW  - MI130110
TI  - CD13 as a new tumor target for antibody-drug conjugates: validation with the conjugate MI130110
TY  - journal article
ER  -